NASDAQ · Financial Statements

Inhibrx Biosciences, Inc. (INXB) Financial Statements

$15.86 NASDAQ: INXB Market Cap $225.87M

Full income statement, balance sheet, and cash flow statement for Inhibrx Biosciences, Inc. (INXB), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio-0.67
EV / EBITDA-12.36
FCF Yield-8.16%
Quick Ratio5.07
Interest Coverage-8.21
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
INXB Overview INXB Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.